FDA Adverse Event Injury Summary report: N

AUTOSOFT XC

MDR report key: 21155168 · Received January 15, 2025

Report

Report Number
3003442380-2024-36972
Event Type
Injury
Date Received
January 15, 2025
Date of Event
December 10, 2024
Report Date
January 26, 2026
Manufacturer
UNOMEDICAL UM-D
Product Code
FPA
PMA / PMN Number
K032854
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

H11: SINCE NO LOT NUMBER IS AVAILABLE. A DETAILED INVESTIGATION, TESTS ON REFERENCE SAMPLES OR BATCH REVIEW CANNOT BE CONDUCTED. THEREFORE, THIS COMPLAINT WILL BE CLOSED, THIS ISSUE WILL BE MONITORED THROUGH POST MARKETING SURVEILLANCE (PMS) PRODUCT TRENDS AND MALFUNCTION. IF ANY TRENDS PICKED UP, THIS WOULD FLAG ON THE TRIPS AND ALERTS ACCORDING TO THE ON MARKET QUALITY REVIEW (OMQR) PROCEDURE. INITIAL AND FINAL MDR 2091718 - MDR 3003442380-2024 - 3003442380-2024-36972 - DEVICE 2 OF 2.

Additional Manufacturer Narrative · 0

SUPPLEMENTAL REPORT 01 - MDR (B)(4)- MDR 3003442380-2024-36972. UNOMEDICAL HEREBY SUBMITS THIS SUPPLEMENTAL REPORT AS PART OF ITS COMPLAINT REMEDIATION ACTIVITIES CONDUCTED UNDER A CAPA/FDA ACTION PLAN. THIS SUBMISSION INCLUDES A RETROSPECTIVE REASSESSMENT OF PREVIOUSLY EVALUATED COMPLAINTS. UNOMEDICAL IS PROVIDING THIS SUPPLEMENTAL INFORMATION IN ACCORDANCE WITH THE REPORTING REQUIREMENTS SET FORTH IN 21 CFR PART 803. ANY FIELDS LEFT BLANK INDICATE THAT THE INFORMATION IS UNKNOWN, UNAVAILABLE, OR REMAINS UNCHANGED. ADDITIONAL INFORMATION - THIS MEDICAL DEVICE REPORT (MDR) IS BEING SUBMITTED TO INCLUDE THE BELOW: H6: INVESTIGATION RESULTS UNDER TYPE OF INVESTIGATION, INVESTIGATION FINDINGS, INVESTIGATION CONCLUSIONS. H11: INVESTIGATION SUMMARY. COMPLAINT INVESTIGATION RESULTS. A COMPLAINT INVESTIGATION WAS CONDUCTED BASED ON THE EVENT DESCRIPTION AND THE ASSIGNED MALFUNCTION CODE SOFT CANNULA BENT/KINKED/CRIMPED AFTER REMOVAL -BLOCKAGE. ADDITIONAL INFORMATION WAS REQUESTED TO SUPPORT THE INVESTIGATION; HOWEVER, A LOT NUMBER INFORMATION WAS NOT PROVIDED. NO DEVICE, DEVICE COMPONENTS, OR OTHER VISUAL OR PHYSICAL EVIDENCE WAS MADE AVAILABLE FOR EVALUATION. CONSEQUENTLY, VISUAL INSPECTION, RETAIN-SAMPLE TESTING, OR THE ASSESSMENT OF POTENTIAL PRODUCT PERFORMANCE ISSUES, COMPONENT INTEGRITY, OR MANUFACTURING DEFECTS COULD NOT BE PERFORMED. IN RESPONSE TO THE COMPLAINT AND DUE TO THE ABSENCE OF A SPECIFIC LOT NUMBER, A HIGH LEVEL INVESTIGATION WAS CONDUCTED FOR THE AUTOSOFT XC PRODUCT FAMILY AND THE ASSIGNED MALFUNCTION. THE INVESTIGATION ENCOMPASSED AN EQMS SEARCH, ASSESSMENT OF COMPLAINT TRENDS, AND THE REVIEW OF RISK MANAGEMENT FILES. NO SYSTEMIC ISSUES WERE IDENTIFIED. PLEASE REFER TO THE ATTACHED MEMO FOR FULL DETAILS: AUTOSOFT XC_CANNULA_.DOCX ENCLOSURE 1: ELECTRONIC QUALITY MANAGEMENT SYSTEM (EQMS) SEARCH RESULTS . ENCLOSURE 2: MAINTENANCE RESULTS . ENCLOSURE 3: RAW DATA FOR COMPLAINT TRENDING . CORRECTIVE AND PREVENTIVE ACTION (CAPA) DETERMINATION. BASED ON THE INVESTIGATION, NO FURTHER ACTION IS REQUIRED. THE RECORD WILL BE CLOSED AND MONITORED THROUGH TRACKING AND TRENDING PER (WORK INSTRUCTION WI) (MONTHLY TRIPS AND ALERTS). COMPLAINT UNCONFIRMED: FOLLOWING INVESTIGATION, THE REPORTED FAILURE COULD NOT BE CONFIRMED FOR THIS COMPLAINT. COMPLAINT INVESTIGATION - CONCLUSION. DUE TO THE ABSENCE OF A LOT NUMBER AND RETURNED PRODUCT, THE INVESTIGATION WAS LIMITED TO A HIGH LEVEL REVIEW OF THE AUTOSOFT XC PRODUCT FAMILY, INCLUDING AN EQMS SEARCH, COMPLAINT TRENDING, AND REVIEW OF APPLICABLE RISK MANAGEMENT DOCUMENTATION. NO EVIDENCE OF A SYSTEMIC ISSUE WAS IDENTIFIED. NO FURTHER ACTION IS REQUIRED AT THIS TIME, AND THE RECORD WILL BE CLOSED WITH CONTINUED MONITORING THROUGH ROUTINE TRACKING AND TRENDING. THE RECORD MAY BE REASSESSED IF ADDITIONAL INFORMATION BECOMES AVAILABLE.

Description of Event or Problem · 0

REFERENCE NUMBER (B)(4). EVENT OCCURRED IN THE UNITED STATES. IT WAS REPORTED THAT THE PATIENT FACED BENT CANNULA EVENTS ON 10-DEC-2024 LEADING TO HIGH BLOOD GLUCOSE LEVEL AND DIABETIC KETACIDOSIS. THEREFORE, THE PATIENT WAS HOSPITALISED FOR THE DIABETIC KETOACIDOSIS. COMPANY DO NOT SEE BENT/KINKING AS BEING RELATED TO HUMAN FACTORS, BUT RATHER AS A TRAINING ISSUE INCLUDING CORRECT CHOICES OF INSERTION SITES AND INFUSION SETS AND CANNULA LENGTH. FURTHERMORE, THE SOFT CANNULA IS A FLEXIBLE MATERIAL THAT DURING USE AND UPON REMOVAL CAN BEND SLIGHTLY. NO FURTHER INFORMATION WAS AVAILABLE

Description of Event or Problem · 0

TO DATE NO ADDITIONAL PATIENT OR EVENT DETAILS HAVE BEEN RECEIVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1486570 AUTOSOFT XC UNKNOWN FPA UNOMEDICAL UM-D UNKNOWN UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 8 YR Female Hospitalization| R